Healthcare -
Biotechnology - NASDAQ - US
$ 7.5
-25.1 %
$ 578 M
Market Cap
-2.44
P/E
REPL - REVENUE
Revenue REPL - Replimune Group, Inc.
0
LAST VALUE
0.00%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR